Evidence map›Paper›PMID 40435508›Full record

ArticleBlood advances2025

Emergent BAX-mutated clonal hematopoiesis after venetoclax-based therapy for breast cancer.

Ing S Tiong, Tamia Nguyen, Chong C Chua, Charis E Teh, Christine Muttiah, Sarah Ftouni, John F Seymour, Daniel Gray, Andrew W Roberts, Sarah-Jane Dawson and 2 more

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Blood advances, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed.

  1. In vitro study and in silico reveal Teucrium Polium L. methanolic extract as an apoptosis inducer and a potential Bcl-2 inhibitor for breast cancer.Saudi pharmaceutical journal : SPJ : the official publication of the Saudi Pharmaceutical Society · 2026
    Article
  2. Article
  3. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors.

Ing S TiongPeter MacCallum Cancer Centre, Melbourne, VIC, Australia.ORCID 0000-0001-7417-4343
Tamia NguyenPeter MacCallum Cancer Centre, Melbourne, VIC, Australia.
Chong C ChuaThe Walter and Eliza Hall Institute of Medical Research, Melbourne, VIC, Australia.
Charis E TehThe Walter and Eliza Hall Institute of Medical Research, Melbourne, VIC, Australia.
Christine MuttiahThe Walter and Eliza Hall Institute of Medical Research, Melbourne, VIC, Australia.ORCID 0000-0001-7166-1728
Sarah FtouniPeter MacCallum Cancer Centre, Melbourne, VIC, Australia.
John F SeymourPeter MacCallum Cancer Centre, Melbourne, VIC, Australia.ORCID 0000-0003-2188-6835
Daniel GrayThe Walter and Eliza Hall Institute of Medical Research, Melbourne, VIC, Australia.ORCID 0000-0002-8457-8242
Andrew W RobertsPeter MacCallum Cancer Centre, Melbourne, VIC, Australia.ORCID 0000-0002-7341-5720
Sarah-Jane DawsonPeter MacCallum Cancer Centre, Melbourne, VIC, Australia.
Geoffrey J LindemanPeter MacCallum Cancer Centre, Melbourne, VIC, Australia.ORCID 0000-0001-9386-2416
Piers BlomberyPeter MacCallum Cancer Centre, Melbourne, VIC, Australia.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Identifiers

PMID40435508
PMCPMC12405625

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.